Dr. Margaret Callahan, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Skin Cancer
Studies Melanoma
11 reported clinical trials
20 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
BRAF positive
2Melanoma
Stage IV
Stage III
ctDNA
Affiliated Hospitals
Clinical Trials Margaret Callahan, MD is currently running
BMS-986340 + Nivolumab/Docetaxel
for Cancer
This trial tests a new drug, BMS-986340, alone and with other cancer treatments (nivolumab and docetaxel) in patients with advanced solid tumors. The goal is to find out if it is safe and effective in treating these cancers.
Recruiting1 award Phase 1 & 26 criteria
IMC-F106C Combinations
for Solid Cancers
This trial tests IMC-F106C, a treatment that helps the immune system target and kill cancer cells in adults with advanced cancers. It guides immune cells to attack cancer cells more effectively.
Recruiting1 award Phase 1 & 2
More about Margaret Callahan, MD
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Margaret Callahan, MD has experience with
- Nivolumab
- Relatlimab
- Pembrolizumab
- Nivolumab-Relatlimab
- IO102/IO103
- ⁸⁹Zr-Df-IAB22M2C
Breakdown of trials Margaret Callahan, MD has run
Skin Cancer
Melanoma
Stomach Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margaret Callahan, MD specialize in?
Margaret Callahan, MD focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Margaret Callahan, MD currently recruiting for clinical trials?
Yes, Margaret Callahan, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Margaret Callahan, MD has studied deeply?
Yes, Margaret Callahan, MD has studied treatments such as Nivolumab, Relatlimab, Pembrolizumab.
What is the best way to schedule an appointment with Margaret Callahan, MD?
Apply for one of the trials that Margaret Callahan, MD is conducting.
What is the office address of Margaret Callahan, MD?
The office of Margaret Callahan, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.